Incorporated

Qualcomm Schedules First Quarter Fiscal 2024 Earnings Release and Conference Call

Retrieved on: 
Wednesday, January 17, 2024

Qualcomm Incorporated (NASDAQ: QCOM) today announced that it will publish the Company’s financial results for its first quarter fiscal 2024 on Wednesday, January 31, 2024, after the close of the market on the Company’s Investor Relations website, at https://investor.qualcomm.com/financial-information .

Key Points: 
  • Qualcomm Incorporated (NASDAQ: QCOM) today announced that it will publish the Company’s financial results for its first quarter fiscal 2024 on Wednesday, January 31, 2024, after the close of the market on the Company’s Investor Relations website, at https://investor.qualcomm.com/financial-information .
  • The earnings release will also be furnished to the Securities and Exchange Commission (SEC) on a Form 8-K, which will be available on the SEC website at http://www.sec.gov .
  • Qualcomm will host a conference call to discuss its first quarter fiscal 2024 results which will be broadcast live on January 31, 2024, beginning at 1:45 p.m. Pacific Time (PT) at https://investor.qualcomm.com/news-events/events .
  • To listen to the replay via telephone, U.S. callers may dial (877) 660-6853 and international callers may dial (201) 612-7415.

Stifel Declares Quarterly Common Stock Cash Dividend And Declares Preferred Stock Cash Dividend

Retrieved on: 
Wednesday, November 15, 2023

The Board of Directors also declared a quarterly cash dividend on the outstanding shares of its 6.25% Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”), 6.125% Non-Cumulative Perpetual Preferred Stock, Series C (the “Series C Preferred Stock”), and 4.50% Non-Cumulative Perpetual Preferred Stock, Series D (the “Series D Preferred Stock”).

Key Points: 
  • The Board of Directors also declared a quarterly cash dividend on the outstanding shares of its 6.25% Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”), 6.125% Non-Cumulative Perpetual Preferred Stock, Series C (the “Series C Preferred Stock”), and 4.50% Non-Cumulative Perpetual Preferred Stock, Series D (the “Series D Preferred Stock”).
  • The declared cash dividend on the Series B Preferred Stock, Series C Preferred Stock, and Series D Preferred Stock is for the period from September 15, 2023, up to, but excluding, December 15, 2023.
  • The declared cash dividend equated to approximately $0.390625 per depositary share, or $390.625 per share of the Series B Preferred Stock outstanding.
  • The declared cash dividend equated to approximately $0.3828125 per depositary share, or $382.8125 per share of the Series C Preferred Stock outstanding.

Mastercard Board of Directors Announces Quarterly Dividend and $11 Billion Share Repurchase Program

Retrieved on: 
Tuesday, December 5, 2023

Mastercard Incorporated (NYSE: MA) today announced that its Board of Directors has declared a quarterly cash dividend of 66 cents per share, a 16 percent increase over the previous dividend of 57 cents per share.

Key Points: 
  • Mastercard Incorporated (NYSE: MA) today announced that its Board of Directors has declared a quarterly cash dividend of 66 cents per share, a 16 percent increase over the previous dividend of 57 cents per share.
  • The Board of Directors also approved a new share repurchase program, authorizing the company to repurchase up to $11 billion of its Class A common stock.
  • The new share repurchase program will become effective at the completion of the company’s previously announced $9 billion program (December 2022).
  • As of December 1, 2023, the company had approximately $3.5 billion remaining under the current approved share repurchase program.

McCormick & Company's 2050 Net-Zero Target Validated by Science Based Targets Initiative

Retrieved on: 
Monday, December 11, 2023

HUNT VALLEY, Md., Dec. 11, 2023 /PRNewswire/ -- McCormick & Company, Incorporated (NYSE: MKC), a global leader in flavor, is one of several companies leading the journey to net-zero as it announced today that the Science Based Targets initiative (SBTi) has approved its net-zero science-based target by 2050.

Key Points: 
  • "We are proud to have SBTi approve our 2050 net-zero target, but we also realize this is only the first step in a long journey.
  • In 2022, the Company also had its near-term emission reduction targets approved by SBTi, a 42% absolute reduction across Scopes 1, 2, and 3 by 2030.
  • Utilizing nature-based solutions for the small percentage of emissions which we are unable to eliminate, in line with SBTi guidelines.
  • To learn more about our science-based net-zero target, please visit the Net-Zero section of our Corporate website .

Mars "Reuses" Fan-Favorite Ads for M&Ms®, TWIX®, SNICKERS® and Ben's Original™ to Deliver Message of Hope for Climate Action

Retrieved on: 
Tuesday, November 28, 2023

MCLEAN, Va., Nov. 28, 2023 /PRNewswire/ -- Mars, Incorporated launches a first-of-its-kind digital and out-of-home campaign that 'reuses' fan-favorite advertisements giving them a second life with new messages of hope and progress around climate.

Key Points: 
  • In a first-of-its-kind digital and out-of-home campaign for the company, Mars revives iconic advertisements from beloved brands to engage and inspire the public around climate action.
  • MCLEAN, Va., Nov. 28, 2023 /PRNewswire/ -- Mars, Incorporated launches a first-of-its-kind digital and out-of-home campaign that 'reuses' fan-favorite advertisements giving them a second life with new messages of hope and progress around climate.
  • That is why we decided to use our iconic brands in the adverts consumers know and love and deliver a message of hope and optimism on climate change.
  • We are taking action now to reduce carbon emissions - from working with farmers to protect forests to sourcing renewable electricity.

Mars "Reuses" Fan-Favorite Ads for M&Ms®, TWIX®, SNICKERS® and Ben's Original™ to Deliver Message of Hope for Climate Action

Retrieved on: 
Tuesday, November 28, 2023

MCLEAN, Va., Nov. 28, 2023 /PRNewswire/ -- Mars, Incorporated launches a first-of-its-kind digital and out-of-home campaign that 'reuses' fan-favorite advertisements giving them a second life with new messages of hope and progress around climate.

Key Points: 
  • In a first-of-its-kind digital and out-of-home campaign for the company, Mars revives iconic advertisements from beloved brands to engage and inspire the public around climate action.
  • MCLEAN, Va., Nov. 28, 2023 /PRNewswire/ -- Mars, Incorporated launches a first-of-its-kind digital and out-of-home campaign that 'reuses' fan-favorite advertisements giving them a second life with new messages of hope and progress around climate.
  • That is why we decided to use our iconic brands in the adverts consumers know and love and deliver a message of hope and optimism on climate change.
  • We are taking action now to reduce carbon emissions - from working with farmers to protect forests to sourcing renewable electricity.

Astellas to Acquire Propella Therapeutics

Retrieved on: 
Wednesday, November 15, 2023

TOKYO and PITTSBORO, N.C., Nov. 15, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Propella Therapeutics, Inc. (President and CEO: William Moore, "Propella") today announced that Astellas, through a U.S. subsidiary, and Propella have entered into a merger agreement pursuant to which Astellas will acquire Propella. Propella is a privately held biopharmaceutical company that has leveraged a wholly owned proprietary platform that combines medicinal chemistry with lymphatic targeting to create new oncology drugs.

Key Points: 
  • TOKYO and PITTSBORO, N.C., Nov. 15, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") and Propella Therapeutics, Inc. (President and CEO: William Moore, "Propella") today announced that Astellas, through a U.S. subsidiary, and Propella have entered into a merger agreement pursuant to which Astellas will acquire Propella.
  • Through the acquisition of Propella, Astellas will acquire PRL-02 (abiraterone decanoate), a next-generation androgen biosynthesis inhibitor being developed by Propella to treat prostate cancer.
  • Under the agreement, Astellas will pay approximately US$175million to acquire all of the outstanding common stock and equity interests in Propella.
  • Stifel, Nicolaus & Company, Incorporated is acting as exclusive financial advisor and Cooley LLP provided legal advice to Propella on this transaction.

Stifel to Present at the Wolfe Research Wealth Symposium

Retrieved on: 
Tuesday, November 7, 2023

ST. LOUIS, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced its participation in the Wolfe Research Wealth Symposium Wednesday, November 8, 2023.

Key Points: 
  • ST. LOUIS, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced its participation in the Wolfe Research Wealth Symposium Wednesday, November 8, 2023.
  • Ron Kruszewski, Chairman and CEO, is scheduled to present at 3:40 p.m. Eastern time.
  • A copy of the presentation materials will be made available directly through the Investor Relations section of the company’s website, www.stifel.com , prior to Mr. Kruszewski’s appearance.
  • Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions.

Cegeka and CTG Announce Extension of Tender Offer for All Outstanding Shares of CTG

Retrieved on: 
Friday, November 3, 2023

Computershare Trust Company, N.A., the depositary for the Offer, has indicated that as of 5:00 p.m., Eastern Time, on November 2, 2023, approximately 8,653,044 Shares had been validly tendered into and not validly withdrawn from the Offer, representing approximately 56.9021% of the outstanding Shares.

Key Points: 
  • Computershare Trust Company, N.A., the depositary for the Offer, has indicated that as of 5:00 p.m., Eastern Time, on November 2, 2023, approximately 8,653,044 Shares had been validly tendered into and not validly withdrawn from the Offer, representing approximately 56.9021% of the outstanding Shares.
  • Shareholders that have previously tendered their Shares do not need to re-tender their Shares or take any other action in response to this extension.
  • The Offer was extended to allow additional time for the satisfaction of the Regulatory Condition and the other conditions described in the Offer to Purchase.
  • Requests for documents and questions regarding the Offer may be directed to Georgeson by telephone at 1-866-431-2096.

KBW Ranks No. 1 Across Multiple Categories in 2023 Institutional Investor All-America Survey

Retrieved on: 
Thursday, November 2, 2023

1 firm across multiple categories in the 2023 Institutional Investor (II) All-America survey.

Key Points: 
  • 1 firm across multiple categories in the 2023 Institutional Investor (II) All-America survey.
  • 1 in the II survey, and KBW’s Consumer Finance research team also placed first.
  • 1 in the Financial Institutions Group (FIG) sector, and KBW also had the top-ranked trading/execution team within FIG, in the first such category ever included by II.
  • KBW is the only specialist firm to rank first in any of the sales, trading/execution, and corporate access categories across the II survey, let alone all three.